James Healy, Director, 10% Owner at CinCor Pharma, Inc. (CINC), bought 5,573,949 shares at $16.00 ($5.2M) on 2022-01-11, disclosed to the SEC on 2022-01-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 5,248,949 | $0 | 0.0% |
| 2 | $16.00 | 325,000 | $5.2M | 100.0% |
| Total | $0.93 avg | 5,573,949 | $5.2M | 100% |
| Filing → |
| RAPP | BUY | 2024-06-10 | $9.5M | — | Filing → |
| AVBP | BUY | 2024-01-31 | $8.0M | — | Filing → |
| NTRA | SELL | 2023-12-22 | $37.8M | — | Filing → |